Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraja Parameswaran

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2006
Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotineTanuja Bordia, Neeraja Parameswaran, Hong Fan, et al.
Molecular Pharmacology|June 4, 2005
Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damageSarah E McCallum, Neeraja Parameswaran, Tanuja Bordia, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2008
Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatumKathryn T O'Leary, Neeraja Parameswaran, Louisa C Johnston, et al.
Journal of Neurochemistry|January 18, 2006
Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatmentSarah E McCallum, Neeraja Parameswaran, Tanuja Bordia, et al.
Molecular Pharmacology|February 1, 2005
Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in miceAlbert Lai, Neeraja Parameswaran, Mirium Khwaja, et al.
Journal of Neurochemistry|August 3, 2006
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primatesMaryka Quik, Neeraja Parameswaran, Sarah E McCallum, et al.
Psychopharmacology|August 10, 2006
Guidelines on nicotine dose selection for in vivo researchShannon G Matta, David J Balfour, Neal L Benowitz, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2006
Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotineTanuja Bordia, Neeraja Parameswaran, Hong Fan, et al.
Molecular Pharmacology|June 4, 2005
Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damageSarah E McCallum, Neeraja Parameswaran, Tanuja Bordia, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2008
Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatumKathryn T O'Leary, Neeraja Parameswaran, Louisa C Johnston, et al.
Journal of Neurochemistry|January 18, 2006
Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatmentSarah E McCallum, Neeraja Parameswaran, Tanuja Bordia, et al.
Molecular Pharmacology|February 1, 2005
Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in miceAlbert Lai, Neeraja Parameswaran, Mirium Khwaja, et al.
Journal of Neurochemistry|August 3, 2006
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primatesMaryka Quik, Neeraja Parameswaran, Sarah E McCallum, et al.
Psychopharmacology|August 10, 2006
Guidelines on nicotine dose selection for in vivo researchShannon G Matta, David J Balfour, Neal L Benowitz, et al.
Pageof 2